What is the ELEV stock price prediction for next 2 weeks?

According to our price prediction algorithm,Elevation Oncology, Inc. (ELEV) price will be around $0.35 in the next 2 weeks. This means it will decrease by -2.9863013698630043 from the last closing price. This prediction may vary from other time period filters for ELEV stock.

What can be the highest Possible price of ELEV stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, ELEV can achieve the highest price of $0.36 which is -1.4842014214074206 lower than last closing price. This prediction may vary from other time period filters for ELEV stock.

What can be the lowest Possible price of ELEV stock in next 2 weeks?

As per the forecast and algorithmic analysis, ELEV stock price can be as low as $0.35 which is -4.6171559263226625 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for ELEV stock.

Will ELEV stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that ELEV stock will lose-2.9863013698630043 in the next 2 weeks. This prediction may vary from other time period filters for ELEV stock.

What is ELEV stock last closing price?

Last closing price of ELEV stock was $0.37.

What is ELEV stock price prediction?

ELEV stock price prediction means predicting the future closing prices of ELEV stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of ELEV stock in a certain time period.

How we predict ELEV stock future prices?

If you are searching for ELEV stock forecast, analysis or price prediction, then you might be wondering what Elevation Oncology, Inc. (ELEV) will do in the future. Our ELEV price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This ELEV price prediction will likely answer most of your questions.

How frequent we update ELEV stock predictions?

We are updating the forecasts for the ELEV stock on daily basis.

Is using ML forecasting for ELEV stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for ELEV stock same for all the time periods?

No, the prediction for ELEV stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Elevation Oncology, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$0.370%Since 2 Weeks

Predicted Price$0.35-2.99%For 2 Weeks

Upper Predicted Price$0.36-1.48%For 2 Weeks

Lower Predicted Price$0.35-4.62%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of ELEV will decline by -2.99% over the next 2 Weeks and hit $0.35 by Thursday, August 14, 2025. In that time frame, ELEV's share price is expected to range between $0.35 and $0.36.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Aug 14, 2025	0.35	0.35	0.36
Aug 13, 2025	0.35	0.35	0.36
Aug 12, 2025	0.35	0.35	0.36
Aug 11, 2025	0.35	0.35	0.36
Aug 8, 2025	0.35	0.35	0.36
Aug 7, 2025	0.35	0.36	0.37
Aug 6, 2025	0.35	0.36	0.37
Aug 5, 2025	0.35	0.36	0.36
Aug 4, 2025	0.35	0.36	0.37
Aug 1, 2025	0.35	0.36	0.36

ELEV shares fell -2.12% in Wednesday, July 23, 2025's trading session, dropping from a previous close of $0.37 to move at $0.37. The stock demonstrated notable intraday movement (see ELEV's key stats for a full breakdown), fluctuating between $0.37 and $0.37, a 0 trading range. While recent weeks have seen some volatility, ELEV has managed to secure a -3.87% drop over the past 2 weeks. The downward price movement was accompanied by remained steady trading volume, with approximately 0 shares changing hands, 0 fewer than the previous session. This amounted to $0.00 in total market activity.

Will ELEV Continue Its Downward Trend?

According to analyst ratings and projections for ELEV, Elevation Oncology, Inc. shares are anticipated to decrease by -1.34%, potentially reaching $0.36 per share by August 14, 2025. Short-term technical indicators currently suggest a neutral sentiment for ELEV. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the ELEV stock forecast, now is not the best time to buy ELEV stock because its current trading price is +3.08% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on ELEV covering social and institutional perspectives.

ELEV Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into ELEV's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 36.57% to 48.86%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 46.29%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 44.70%, maintains a neutral outlook for the long term. Insights into ELEV's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Elevation Oncology Short-Term Forecasts

ELEV Forecast For Next 5 Days

Our algorithm anticipates Elevation Oncology (ELEV) stock could hit $0.39 by Aug 22, 2025. This represents a +7.45% fall from today's price, following a -3.87% change over the past five days.

ELEV Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Elevation Oncology, Inc. (ELEV) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $0.37, which would mean a +1.37% increase from the current price of $0.37. Projections for this period range from a high of $0.42 to a low of $0.33.

ELEV Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Elevation Oncology's price over the next three months point to a drop. ELEV stock is expected to peak at $0.00 on Jun 18, 2026 before potentially dipping to $0.00 on Jun 18, 2026. On average, ELEV is likely to trade around $0.30 in the coming 90 days.

Elevation Oncology Stock Forecast 2025

Based on our predictive models, Elevation Oncology (ELEV) is expected to trade between $0.00 and $0.21 throughout 2026. This would result in an average price of $0.30, potentially offering investors a -17.81% return from current levels.

Elevation Oncology, Inc. Monthly Forecast 2025–2026

August 2025

According to our latest forecast models, Elevation Oncology, Inc. (ELEV) is positioned to show a strong performance in August 2025. The price is predicted to move between $0.26 and $0.73, settling at an average of $0.47. This could translate to a +28.77% gain.

September 2025

Based on current market signals, Elevation Oncology, Inc. is projected to trend september 2025. We forecast a trading range from $0.59 to $1.03, with a likely average price of $0.82. Investors could expect a potential return of +124.66%.

October 2025

Our predictive algorithms indicate Elevation Oncology, Inc. stock may see a shift in October 2025. The expected range spans $0.27–$0.80, with an average target of $0.59. This represents a positive outlook and a possible gain of +61.64%.

November 2025

Analyzing established trends, Elevation Oncology, Inc. looks set to move in November 2025. Projections place the stock between $0.16 and $0.51, averaging around $0.38. This suggests a +4.11% gain from current levels.

December 2025

Market indicators suggest Elevation Oncology, Inc. could experience notable changes during December 2025. Prices could fluctuate within $0.00 to $0.42, with a midpoint forecast of $0.30. The stock might deliver a -17.81% loss.

January 2026

Forecasting for January 2026, models estimate that Elevation Oncology, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.21, averaging $0.33. This signals a cautious trajectory with potential returns around -9.59%.

February 2026

According to our latest forecast models, Elevation Oncology, Inc. (ELEV) is positioned to show a strong performance in February 2026. The price is predicted to move between $0.00 and $0.00, settling at an average of $0.42. This could translate to a +15.07% gain.

March 2026

Based on current market signals, Elevation Oncology, Inc. is projected to trend march 2026. We forecast a trading range from $0.00 to $0.00, with a likely average price of $0.40. Investors could expect a potential return of +9.59%.

April 2026

Our predictive algorithms indicate Elevation Oncology, Inc. stock may see a shift in April 2026. The expected range spans $0.00–$0.00, with an average target of $0.33. This represents a cautious outlook and a possible loss of -9.59%.

May 2026

Analyzing established trends, Elevation Oncology, Inc. looks set to move in May 2026. Projections place the stock between $0.00 and $0.00, averaging around $0.30. This suggests a -17.81% loss from current levels.

June 2026

Market indicators suggest Elevation Oncology, Inc. could experience notable changes during June 2026. Prices could fluctuate within $0.00 to $0.00, with a midpoint forecast of $0.16. The stock might deliver a -56.16% loss.

July 2026

Forecasting for July 2026, models estimate that Elevation Oncology, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $0.20. This signals a cautious trajectory with potential returns around -45.21%.

ELEV's history of dividends and stock splits also plays a role in long-term investor confidence.